Abstract
A 14.6-kDa RNase, with a pH optimum of 5.5 and a temperature optimum of 70 °C, was isolated from dried fruiting bodies of the edible mushroom Lactarius flavidulus. The purification procedure involved, in succession, ion exchange chromatography on DEAE-cellulose, CM-cellulose and SP-Sepharose, and finally FPLC-gel filtration on Superdex 75. The RNase was adsorbed on all three ion exchangers. The ranking of its activity toward various polyhomoribonucleotides was poly(C) > poly(G) > poly(A) > poly(U). It suppressed proliferation of HepG2 cells and L1210 cells with an IC50 of 3.19 μM and 6.52 μM, respectively. It also inhibited the activity of HIV-1 reverse transcriptase with an IC50 of 2.55 μM.
Similar content being viewed by others
Introduction
The literature on Lactarius flavidulus is limited to only two reports. Peranylphenols isolated from the mushroom were designated as flavidulols A, B and C,1, 2 which displayed immunosuppressive activity on proliferation of mouse lymphocytes induced by Con A and lipopolysaccharide.2 The literature on other Lactarius species is more abundant but work related to proteins is confined to five papers on lectins and one paper on an enzyme. Panchak and Antonyuk described the purification of a lectin from fruiting bodies of L. pergamenus3 and L. rufus4 and another three lectins have been purified from L. deterrimus,5 L. lignyotus6 and L. deliciosus.7
RNases are found in a host of organisms. Barnase and binase are RNases purified from the bacteria Bacillus amiloliquefaciens and B. internedius, respectively. Despite similarities in structure and physicochemical and catalytic activities, the former is dependent on multifunctional Spo0A regulator controlling sporulation, biofilm formation and cannibalism, whereras binase is synthesized under phosphate starvation. Barnase and binase show some differences in practical applications. Both have been found to be useful in cancer research because of success in targeted delivery and selectivity towards tumor cells.8 Plant RNases can be used as antiproliferative agents targeting human tumors growing in mice.9 Onconase from the frog Rana pipiens has antitumor activity and clinical trials on patients with breast, kidney, lung and pancreatic cancers have been carried out.10 RNases have been isolated from a lot of mushrooms including portabella mushroom,11 Dictyophora indusiata,12 Hypsizigus marmoreus,13 Lyophyllum shimeiji,14 Pleurotus djamar,15 Pleurotus eryngii,16 Russula delica17 and Russulus virescens.18
Mushrooms are abundant in bioactive proteins encompassing lectins, antifungal proteins, ribosome inactivating proteins and RNases.16 RNases isolated from different mushroom species may have distinct N-terminal sequences, pH and temperature optima, and polyhomoribonucleotide specificities.19 In view of this observation and the meager literature on the mushroom L. flavidulus in particular and on proteins from mushrooms of the Lactarius. genus in general, we set out to isolate a RNase from the edible mushroom L. flavidulus. Its biochemical characteristics and biological activities were compared with previously isolated RNases.
Materials and Methods
Isolation of RNase
Dried L. flavidulus (10 g), an edible mushroom, was purchased in the Heilongjiang Province in China. The fruiting bodies were homogenized in distilled water (20 ml g−1). Following centrifugation of the homogenate at 12 000 r.p.m. for 30 min at 4 °C, Tris-HCl buffer (pH 8.0, 1 M) was added to the resulting supernatant until the concentration of Tris reached 10 mM. The supernatant was fractionated by ion exchange chromatography on a 10 cm × 100 cm column of DEAE-cellulose (Sigma, St Louis, MO, USA). After removal of the unadsorbed fraction D1, adsorbed proteins were desorbed stepwise with 50 mM NaCl in the Tris-HCl buffer to yield fraction D2 and then with 300 mM and 1 M NaCl in the Tris-HCl buffer to yield fractions D3 and D4, respectively. Fraction D2 with RNase activity was then subjected to ion exchange chromatography on a 2.5 cm × 30 cm column of CM-cellulose (Sigma) in 10 mM NaAc–HAc buffer (pH 5.2). After removal of the unadsorbed fraction C1 with the same buffer, adsorbed proteins were eluted with 50 mM NaCl in the NaAc–HAc buffer to yield fraction C2 and then with 150 mM and 1 M NaCl in the Tris-HCl buffer to yield fractions C3 and C4, respectively. Fraction C3 with RNase activity was dialyzed and subsequently applied on a 1.0 cm × 10 cm column of SP-Sepharose (GE Healthcare, Piscataway, NJ, USA) in 10 mM phosphate buffer (pH 6.0). Unadsorbed proteins were eluted as fraction SP1 while adsorbed proteins were eluted as fractions SP2 with a linear 0–1 M NaCl concentration gradient. Fraction SP2 with RNase activity was dialyzed and subsequently further purified on a Superdex 75 HR 10/300 column (GE Healthcare) in 0.15 M NH4HCO3 buffer (pH 8.5). The second resulting peak (SU2) represented purified RNase.
Molecular mass determination by sodium dodecyl sulfate polyacrylamide gel electrophoresis and by FPLC-gel filtration
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out by following the procedure of Laemmli and Favre,20 using a 12% resolving gel and a 5% stacking gel. At the end of electrophoresis, the gel was stained with Coomassie brilliant blue. FPLC-gel filtration was conducted using a Superdex 75 HR 10/30 column that had been calibrated with molecular-mass markers (GE Healthcare) using an AKTA Purifier (GE Healthcare).14
Analysis of N-terminal amino acid sequence
Amino acid sequence analysis was performed using an HP G1000A Edman degradation unit and an HP1000 HPLC system (Hewlett-Packard, Palo Alto, CA, USA).17
Assay for activity of RNase
The activity of the purified RNase toward yeast tRNA (Sigma) was determined by measuring the formation of acid-soluble, UV-absorbing species with the method of Wang and Ng.21 The RNase was incubated with 200 μg tRNA in 150 μg of 100 mM MES buffer (pH 6.0) at 37 °C for 15 min. The reaction was stopped by addition of 350 μl of ice-cold 3.5% perchloric acid and leaving the reaction mixture on ice for 15 min. After centrifugation(15 000 g, 15 min) at 4 °C, the OD260 of the supernatant was determined after appropriate dilution. One unit of enzymatic activity is defined as the amount of enzyme that brings about an increase in OD260 of one per minute in the acid-soluble fraction per milliliter of reaction mixture under the specified condition.
Effects of pH and temperature on RNase activity
Citric acid-Na2HPO4 buffer (pH 2.2–8.0, 0.1 M) was used to adjust the pH values of the reaction mixture. The effect of pH on the RNase activity was then determined. Incubation of the reaction mixture was carried out at different temperatures from 4–100 °C to determine the effect of temperature on RNase activity.15
Activity of RNase toward polyhomoribonucleotides
The ribonucleolytic activity of the purified RNase toward polyhomoribonucleotides was assayed with a modification of the method of Wang and Ng.22 Incubation of RNase with 100 μg poly (A), poly (C), poly (G) or poly (U) in 250 μl of 100 mM MES buffer (pH 6.0) was performed at 37 °C for 1 h, before introduction of 250 μl of ice-cold 1.2 N perchloric acid containing 20 mM lanthanum nitrate to stop the reaction. After leaving on ice for 15 min, the sample was centrifuged at 15 000 g for 15 min at 4 °C. The absorbance of the supernatant, after appropriate dilution, was read at 260 nm (in case of poly (A), poly (G) and poly (U)) or at 280 nm (in case of poly (C)).
Assay of antiproliferative activity on tumor cell lines
Human hepatoma HepG2 and mouse leukemia L1210 cells were cultured in RPMI medium supplemented with 10% (v/v) fetal bovine serum, 100 mg l−1 streptomycin and 100 IU ml−1 penicillin, at 37 °C in a humidified atmosphere of 5% (v/v) CO2. Cells were subsequently seeded into 96-well plates at a density of 2 × 103 cells per well, and incubated for 24 h. Different concentrations of the L. flavidulus RNase in 100 μl complete RPMI medium were then added to the wells and incubated for 72 h. MTT quantification assays were then performed to measure the cell viability. Briefly, 20 μl of a 5-mg ml−1 solution of [3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide] (MTT) in phosphate buffered saline was spiked into each well, and the plates were incubated for 4 h. The plates were then centrifuged (2500 r.p.m., 5 min). The supernatant was removed, and 150 μl of dimethyl sulfoxide was added in each well to dissolve the MTT formazan at the bottom of the wells. Ten minutes later, the absorbance at 590 nm was determined with a microplate reader. PBS was added into wells instead of RNase as control.13
Assay for HIV-1 reverse transcriptase (HIV-1 RT) inhibitory activity
The assay for HIV-1 RT inhibitory activity was assessed by using an enzyme-linked immunosorbent assay (ELISA) kit from Boehringer Mannheim (Germany). The assay took advantage of the ability of RT to synthesize DNA, starting from the template/primer hybrid poly (A) oligo(dT)15. The digoxigenin- and biotin-labeled nucleotides in an optimized ratio were incorporated into one of the same DNA molecule, which was freshly synthesized by the RT. The detection and quantification of synthesized DNA as a parameter for RT activity followed sandwich ELISA protocol. Biotin-labeled DNA bound to the surface of microtiter plate modules that had been precoated with streptavidin. An antibody to digoxigenin, conjugated to peroxidase (anti-DIG-POD), subsequently bound to the digoxigenin-labeled DNA. Finally, the peroxidase substrate was added. The peroxidase enzymes catalyzed the cleavage of the substrate and produced a colored reaction product. The absorbance of the samples at 405 nm could be determined by using microtiter plate (ELISA) reader and was directly correlated to the level of RT activity. A fixed amount (4–6 ng) of recombinant HIV-1 RT was used. The inhibitory activity of the RNase was calculated as percentage inhibition as compared with a control without the protein.23
Results
Isolation of RNase
Ion exchange chromatography of an extract of dried L. flavidulus fruit bodies on DEAE-cellulose resolved it into four fractions, an unadsorbed fraction D1 and three adsorbed fractions D2, D3 and D4. RNase activity was confined to fraction D2 (Table 1). Ion exchange chromatography of fraction D2 on CM-cellulose produced a small unadsorbed fraction C1, a much larger adsorbed fraction C2 and two large absorbed fractions C3 and C4. RNase activity was enriched in fraction C3 (Table 1). Fraction C3 was separated on SP-Sepharose into an unadsorbed fraction SP1 and an adsorbed fraction SP2 (Figure 1). The bulk of RNase activity resided in fraction SP2 (Table 1). Fraction SP2 was fractionated on Superdex 75 into two fractions, SU1 and SU2, (Figure 2). RNase activity was found only in fraction SU2 (Table 1).
Molecular mass determination
Fraction SU2 displayed a molecular mass of 14.6 kDa in gel filtration on Superdex 75 (Figure 2) and a single band with the same molecular mass in SDS-PAGE (Figure 3).
N-terminal sequence
The N-terminal sequence of the purified RNase is ATFVATIATNTLGTN. It exhibited little similarity to counterparts from other mushrooms (Table 2).
Optimum pH and temperature
The activity of the purified RNase was maximum at pH 5.5. The activity of the RNase increased steadily from pH 3.0 until it reached its maximum at pH 5.5, and decreased steadily from pH 5.5 until it reached residual level at pH 8.0 (Figure 4). The activity fell precipitously when the temperature was raised from 70–90 °C. The activity observed at 100 °C was similar to that at 37 °C (Figure 5).
Polyhomoribonucleotide specificity
The RNase exerted a specific ribonucleolytic activity of 25.8, 3.5, 78.1 and 102.4 U mg−1 toward poly (A), poly (U), poly (G) and poly (C), respectively.
Antiproliferative activity on cancer cells
Proliferation of the cancer cell lines HepG2 and L1210 was inhibited by the RNase, with IC50 values of 3.19 μM and 6.52 μM, respectively (Table 3).
HIV-1 reverse transcriptase inhibitory activity
The purified RNase inhibited HIV-1 reverse transcriptase, with an IC50 value of 2.55 μM. (Table 3).
Discussion
L. flavidulus mushroom RNase has a molecular mass (14.6 kDa) in the vicinity of those of Lyophyllum shimeiji (14.5 kDa),14 Pleurotus pulmonarius24 and Agaricus bisporus RNases (14 kDa)11 and P. eryngii RNase (16 kDa).16 It is larger than that of P. ostreatus RNase (9 kDa)25 but smaller than those of Russula virescens RNase (28 kDa),18 P. tuber-regium RNase (29 kDa),26 Thelephora ganbajum RNase (30 kDa)27 and straw mushroom RNase (42.5 kDa).21
L. flavidulus RNase is characterized by an N-terminal sequence distinctly different from those of previously reported RNases of mushroom, plant and animal origins. It is noteworthy that RNases of very few mushrooms except those of Irpex lactius and Lentinus edodes exhibit pronounced sequence homology.28, 29
The optimum pH (pH 5.5) for L. flavidulus RNase is different from pH 4.5 for portabella mushroom11 and R. virescens RNases,18 and pH 8.0 for P. pulmonarius.24
L. flavidulus RNase is markedly more thermostable than T. ganbajun RNase. In the latter RNase, activity is much attenuated at 80 °C compared with that at 20 °C and is indiscernible at 100 °C.27 On the other hand, the activity of L. flavidulus RNase was unaltered at 90 °C, thus it is a thermostable RNase.
L. flavidulus RNase is specific for poly(C). RNases from R. virescens18 and Termitomyces globulus27 manifest co-specificity for poly(A) and poly(C). Portabella mushroom RNase exhibits ribonucleolytic activity toward poly(A), poly(C) and poly(U).11 L. sajor-caju RNase is poly(U)-specific.30 On the other hand, P. tuber-regium22 and P. ostreatus31 RNases are specific for poly(G).
Like other mushroom RNases, L. flavidulus RNase exhibits antiproliferative activity towards HepG2 and L1210 cells, and inhibits the activity of HIV-1 reverse transcriptase. However, the potencies of the antiproliferative and HIV-1 reverse transcriptase inhibitory activities are higher than those of the majority of other mushrooms reported previously.32
RNase-controlled RNA degradation is a determining factor in the control of gene expression, maturation and turnover, which are further associated with the progression of cancers and infectious diseases. Fang and Ng32 presented a review of the representative RNases of fungal, bacterial, plant and animal origins and outlined their potential medicinal value in the treatment of tumor and AIDS. Among them, the most clinically promising RNases are mushroom RNases, binase and barnase from bacteria, ginseng RNases and onconase from frog (R. pipiens). Fast developing protein engineering of RNase, which displays more potent cytotoxic activity and greater selectivity for malignant cells, has also aroused the interest of researchers. The multiple anti-cancer mechanisms of RNase are also included.
It is likely that the antiproliferative activity demonstrated herein is correlated with antitumor activity in vivo as reported in the literature. The IC50 values (24 h) of Momodica charantia lectin (MCL) for nasopharygeal carcinoma cells CNE-1 and CNE-2 cells were 6.9±0.2 μM and 7.4±0.4 μM, respectively. Treatment with 1 mg M. charantia lectin per kg body weight for 12 consecutive days (i.p., 1.0 mg kg−1 per day) resulted in nearly 45% reduction of tumor volume.33 Russula lepida lectin exhibited antiproliferative activity toward hepatoma HepG2 cells and human breast cancer MCF-7 cells with an IC50 of 1.6 mM and 0.9 mM, respectively. Daily i.p. injections of R. lepida lectin (5.0 mg kg−1 body weight per day for 20 days) brought about 67.6% reduction in the weight of S-180 tumor.34 The anti-HIV reverse transcriptase activity shown in the present study is also likely to be meaningful regarding inhibition of HIV in view of the following findings. Balzarini et al.35 reported that the mannose-specific lectins from Cymbidium hybrid, Epiactis helleborine and Listeria ovata and the N-acetylglucosamine-specific lectin from Urticadioica potently and selectively inhibited HIV-I and HIV-2 in MT-4 cells. The C. hybrid and E. helleborine lectins had an IC50 of 40–80 ng ml−1, whereas the U. dioica lectin had an IC50 value of 0.3–9 pg ml−1.
L. flavidulus RNase is a new protein as suggested by the novel N-terminal sequence. It has some novel characteristics including activity at high temperatures, and a pH optimum and base specificity different from some of the isolated mushroom RNases (Table 4). It exhibits antiproliferative activity, toward tumor cells, and anti-HIV-1 reverse transcriptase activity, which have not been demonstrated for the majority of the isolated mushroom RNases.
References
Takahashi, A., Kusano, G., Ohta, T. & Nozoe, S. The constituents of Lactarius flavidulus. Imai. Chem. Pharm. Bull. (Tokyo) 7, 2366–2370 (1988).
Fujimoto, H., Nakayama, Y. & Yamazaki, M. Identification of immunosuppressive components of a mushroom, Lactarius flavidulus. Chem. Pharm. Bull. 4, 654–658 (1993).
Panchak, L. V. & Antonyuk, V. O. Purification of a lectin from fruit bodies of Lactarius pergamenus (fr.) Fr. and studies of its properties. Biochemistry (Mosc) 4, 438–449 (2011).
Panchak, L. V. & Antoniuk, V. O. Purification of lectin from fruiting bodies of Lactarius rufus (scop.: Fr.)Fr. and its carbohydrate specificity. Ukr. Biokhim. Zh. 2, 123–128 (2007).
Giollant, M. et al. Characterization of a lectin from Lactarius deterrimus (research on the possible involvement of the fungal lectin in recognition between mushroom and spruce during the early stages of mycorrhizae formation). Plant. Physiol. 2, 513–522 (1993).
Sychrova, H., Ticha, M. & Kocourek, J. Studies on lectins. Lix. Isolation and properties of lectins from fruiting bodies of Xerocomus chrysenteron and Lactarius lignyotus. Can. J. Biochem. Cell. Biol. 7, 700–704 (1985).
Guillot, J., Giollant, M., Damez, M. & Dusser, M. Isolation and characterization of a lectin from the mushroom, Lactarius deliciosus. J. Biochem. 6, 840–845 (1991).
Ulyanova, V., Vershinina, V. & Ilinskaya, O. Barnase and binase: twins with distinct fates. FEBS. J. (2011).
Matousek, J. & Matousek, J. Plant ribonucleases and nucleases as antiproliferative agents targeting human tumors growing in mice. Recent. Pat. DNA. Gene. Seq. 1, 29–39 (2010).
Zwolinska, M. & Smolewski, P. Onconase: a ribonuclease with antitumor activity. Postepy. Hig. Med. Dosw. (Online), 58–66 (2010).
Wang, H. X. & Ng, T. B. A novel ribonuclease from fresh fruiting bodies of the portabella mushroom Agaricus bisporus. Biochem. Cell. Biol. 2, 178–183 (2006).
Wang, H. & Ng, T. B. A novel ribonuclease from the veiled lady mushroom Dictyophora indusiata. Biochem. Cell. Biol. 6, 373–377 (2003).
Guan, G. P., Wang, H. X. & Ng, T. B. A novel ribonuclease with antiproliferative activity from fresh fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochim. Biophys. Acta. 12, 1593–1597 (2007).
Zhang, R. Y., Zhang, G. Q., Hu, D. D., Wang, H. X. & Ng, T. B A novel ribonuclease with antiproliferative activity from fresh fruiting bodies of the edible mushroom Lyophyllum shimeiji. Biochem. Genet. 7–8, 658–668 (2010).
Wu, X., Zheng, S., Cui, L., Wang, H. & Ng, T. B. Isolation and characterization of a novel ribonuclease from the pink oyster mushroom Pleurotus djamor. J. Gen. Appl. Microbiol. 3, 231–239 (2010).
Ng, T. B. & Wang, H. X. A novel ribonuclease from fruiting bodies of the common edible mushroom Pleurotus eryngii. Peptides 8, 1365–1368 (2004).
Zhao, S. et al. An antiproliferative ribonuclease from fruiting bodies of the wild mushroom Russula delica. J. Microbiol. Biotechnol. 4, 693–699 (2010).
Wang, H. & Ng, T. B. A ribonuclease with distinctive features from the wild green-headed mushroom Russulus virescens. Biochem. Biophys. Res. Commun. 4, 965–968 (2003).
Ng, T. B. Peptides and proteins from fungi. Peptides 6, 1055–1073 (2004).
Laemmli, U. K. & Favre, M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J. Mol. Biol. 4, 575–599 (1973).
Wang, H. & Ng, T. B. Isolation of a new ribonuclease from fresh fruiting bodies of the straw mushroom. Biochem. Biophys. Res. Commun. 3, 714–718 (1999).
Wang, H. X. & Ng, T. B. Purification and characterization of a potent homodimeric guanine-specific ribonuclease from fresh mushroom (Pleurotus tuber-regium) sclerotia. Int. J. Biochem. Cell. Biol. 5, 483–490 (2001).
Zhang, G. Q., Sun, J., Wang, H. X. & Ng, T. B. A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa. Acta. Biochim. Pol. 3, 415–421 (2009).
Ye, X. Y. & Ng, T. B. A novel and potent ribonuclease from fruiting bodies of the mushroom Pleurotus pulmonarius. Biochem. Biophys. Res. Commun. 2, 857–861 (2002).
Ye, X. Y. & Ng, T. B. A novel peptide with ribonuclease and translation-inhibitory activities from fruiting bodies of the oyster mushroom Pleurotus ostreatus. J. Pept. Sci. 6, 235–240 (2002).
Wang, H. X., Ng, T. B. & Ooi, V. E. A ribonuclease from sclerotia of the edible mushroom Pleurotus tuber-regium. Biochem. Biophys. Res. Commun. 3, 544–546 (1998).
Wang, H. X. & Ng, T. B. Purification of a novel ribonuclease from dried fruiting bodies of the edible wild mushroom Thelephora ganbajun. Biochem. Biophys. Res. Commun. 2, 855–859 (2004).
Watanabe, H. et al. Base non-specific acid ribonuclease from irpex lacteus, primary structure and phylogenetic relationships in RNase T2 family enzyme. Biosci. Biotechnol. Biochem. 11, 2097–2103 (1995).
Kobayashi, H. et al. A new type of RNase T2 ribonuclease in two basidiomycetes fungi, Lentinus edodes and Irpex lacteus. Biosci. Biotechnol. Biochem. 10, 2307–2310 (2003).
Ngai, P. H. & Ng, T. B. A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju. Peptides 1, 11–17 (2004).
Nomura, H. et al. Purification and primary structure of a new guanylic acid specific ribonuclease from Pleurotus ostreatus. J. Biochem. 1, 26–33 (1994).
Fang, E. F. & Ng, T. B. Ribonucleases of different origins with a wide spectrum of medicinal applications. Biochim. Biophys. Acta. 1, 65–74 (2011).
Fang, E. F. et al. Momordica charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo. Cancer. Prev. Res. (Phila) e-pub ahead of print (2011).
Zhang, G., Sun, J., Wang, H. & Ng, T. B. First isolation and characterization of a novel lectin with potent antitumor activity from a Russula mushroom. Phytomedicine 10, 775–781 (2010).
Balzarini, J. et al. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (n-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral. Res. 2, 191–207 (1992).
Wang, H. & Ng, T. B. Isolation of a new ribonuclease from fruiting bodies of the silver plate mushroom Clitocybe maxima. Peptides 6, 935–939 (2004).
Wang, H. X., Ng, T. B. & Chiu, S. W. A distinctive ribonuclease from fresh fruiting bodies of the medicinal mushroom Ganoderma lucidum. Biochem. Biophys. Res. Commun. 2, 519–522 (2004).
Ye, X. Y. & Ng, T. B. Purification and characterization of a new ribonuclease from fruiting bodies of the oyster mushroom Pleurotus ostreatus. J. Pept. Sci. 2, 120–124 (2003).
Acknowledgements
This work was financially supported by National Grants of China (2010CB732202).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wu, Y., Wang, H. & Ng, T. Purification and characterization of a novel RNase with antiproliferative activity from the mushroom Lactarius flavidulus. J Antibiot 65, 67–72 (2012). https://doi.org/10.1038/ja.2011.112
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ja.2011.112
Keywords
This article is cited by
-
Anticancer potentiality and mode of action of low-carbohydrate proteins and peptides from mushrooms
Applied Microbiology and Biotechnology (2020)
-
Fungal proteinaceous compounds with multiple biological activities
Applied Microbiology and Biotechnology (2016)
-
Isolation of a Ribonuclease with Antiproliferative and HIV-1 Reverse Transcriptase Inhibitory Activities from Japanese Large Brown Buckwheat Seeds
Applied Biochemistry and Biotechnology (2015)